AlphaCrest Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.01M Buy
2022
Q2
Sell
2022
Q1
$509K Buy
2021
Q4
$277K Sell
2021
Q3
$582K Sell
2021
Q2
$1.22M Buy
2020
Q4
Sell
2020
Q3
$538K Buy
2020
Q2
$214K Sell
2020
Q1
$325K Buy
2019
Q3
Sell
2019
Q2
$274K Buy